| Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening M Boretto, N Maenhoudt, X Luo, A Hennes, B Boeckx, B Bui, R Heremans, ... Nature cell biology 21 (8), 1041-1051, 2019 | 328 | 2019 |
| Developing organoids from ovarian cancer as experimental and preclinical models N Maenhoudt, C Defraye, M Boretto, Z Jan, R Heremans, B Boeckx, ... Stem Cell Reports 14 (4), 717-729, 2020 | 130 | 2020 |
| Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review S Dumont, Z Jan, R Heremans, T Van Gorp, I Vergote, D Timmerman Journal of ovarian research 12 (1), 105, 2019 | 35 | 2019 |
| Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3) R Heremans, T Van Den Bosch, L Valentin, L Wynants, MA Pascual, ... Ultrasound in Obstetrics & Gynecology 60 (2), 243-255, 2022 | 23 | 2022 |
| Organoids of the female reproductive tract: innovative tools to study desired to unwelcome processes R Heremans, Z Jan, D Timmerman, H Vankelecom Frontiers in Cell and Developmental Biology 9, 661472, 2021 | 22 | 2021 |
| Signs and symptoms associated with uterine cancer in pre-and postmenopausal women S Boeckstaens, S Dewalheyns, R Heremans, R Vikram, D Timmerman, ... Heliyon 6 (11), 2020 | 19 | 2020 |
| Imaging in gynecological disease (24): Clinical and ultrasound characteristics of ovarian mature cystic teratomas R Heremans, L Valentin, P Sladkevicius, S Timmerman, F Moro, ... Ultrasound in Obstetrics & Gynecology 60 (4), 549-558, 2022 | 13 | 2022 |
| Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors C Landolfo, ETL Achten, J Ceusters, T Baert, W Froyman, R Heremans, ... Gynecologic Oncology 159 (3), 811-819, 2020 | 12 | 2020 |
| Pan-cancer detection and typing by mining patterns in large genome-wide cell-free DNA sequencing datasets H Che, T Jatsenko, L Lenaerts, L Dehaspe, L Vancoillie, N Brison, I Parijs, ... Clinical Chemistry 68 (9), 1164-1176, 2022 | 7 | 2022 |
| The risk of endometrial malignancy and other endometrial pathology in women with abnormal uterine bleeding: An ultrasound-based model development study by the IETA group L Wynants, JYJ Verbakel, L Valentin, B De Cock, MA Pascual, FPG Leone, ... Gynecologic and Obstetric Investigation 87 (1), 54-61, 2022 | 6 | 2022 |
| Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer VI Vanderstichele A, Busschaert P, Landolfo C, Olbrecht S, Coosemans A ... NPJ Genomic Medicine 7 (1), 30, 2022 | 6 | 2022 |
| Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study JY Verbakel, R Heremans, L Wynants, E Epstein, B De Cock, MA Pascual, ... International Journal of Gynecology & Obstetrics 159 (1), 103-110, 2022 | 3 | 2022 |
| Risk of endometrial cancer in asymptomatic postmenopausal women in relation to ultrasonographic endometrial thickness R Heremans, S Guerriero, T Van den Bosch, the IETA consortium Am J Obstet Gynecol 229 (1), 85-86, 2023 | 2 | 2023 |
| OC19.01: Prediction of outcome in endometrial cancer improved by combining traditional with sonographic and demographic parameters: IETA4 cohort follow-up Ultrasound Obstet Gynecol 62 (S1), 43-44, 2023 | 1 | 2023 |
| OC04. 01: Imaging in gynecology: mature cystic teratoma of the ovary. R Heremans, W Froyman, L Valentin, P Sladkevicius, C Van Holsbeke, ... Ultrasound in Obstetrics & Gynecology 54, 2019 | 1 | 2019 |
| Clinical Judgment, Ultrasonography and Organoid Technology to improve Diagnostic and Therapeutic Strategies for Endometrial Pathology–An Endometrial Elegy R Heremans | | 2024 |
| Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery C Landolfo, J Ceusters, L Valentin, W Froyman, T Van Gorp, R Heremans, ... Br J Cancer, 10.1038/s41416-024-02578-x, 2024 | | 2024 |
| Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors A Coosemans, J Ceusters, C Landolfo, T Baert, W Froyman, R Heremans, ... medRxiv, 2024.03. 14.24304282, 2024 | | 2024 |
| Prospective geographic and temporal validation of three published mathematical models to calculate risk of endometrial malignancy in patients with postmenopausal bleeding R Heremans, T Van den Bosch, P Sladkevicius, MA Pascual, JL Alcazar, ... Ultrasound Obstet Gynecol, 2023 | | 2023 |
| Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA‐1 multinomial regression model … R Heremans, L Wynants, L Valentin, FPG Leone, PM Angela, R Fruscio, ... Ultrasound Obstet Gynecol, 10.1002/uog.27530, 2023 | | 2023 |
